The market may be edging higher today, but the same cannot be said for the ASX All Ords share in this article.

In morning trade, investors have sold this share down by as much as 30% to $1.75.

Which ASX All Ords share?

The share that is crashing down to earth on Wednesday is Cogstate Ltd (ASX: CGS).

It is a neuroscience technology company aiming to optimise brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare.

The company highlights that its technologies provide rapid, reliable, and highly sensitive computerised cognitive tests across a growing list of domains. These support partners in the delivery of electronic clinical outcome assessment (eCOA) solutions that replace costly and error-prone paper assessments with real-time data capture.

Why is it crashing?

Investors have been selling down the ASX All Ords share following the release of a disappointing business update.

According to the release, timing-related deferrals are expected to have a short-term impact on reported revenue and profitability in the first half of FY 2026.

It notes that Clinical Trial sales contracts are progressing well and it expects to execute sales contracts of approximately $37 million to $40 million during the first half. This represents 82% to 97% growth on the prior corresponding period. It will also be the company’s second-best half-year result for contracts executed.

This performance is being supported by a record level of pipeline opportunities and ongoing conversion of those opportunities into contracted work.

However, timing delays are expected to impact revenue recognition in the half. This is primarily due to contracts signed late in the December quarter, which provide limited time for revenue to be recognised within the period.

Additionally, management notes that the mix of revenue is a contributing factor. Upfront license fees will represent a smaller share of revenue, with license revenue expected to be approximately 19% to 20% of total revenue in the first half. This is consistent with the 19% recorded in the prior corresponding period, but down from 31% in the second half of FY 2025.

As a result, total revenue for the first half of FY 2026 is now forecast to be in the range of $25 million to $26 million. This is an increase of approximately 5% to 9% on the prior corresponding period. Disappointingly, it falls short of its previous guidance for between 18% to 20% revenue growth.

Making things worse is that management expects its costs to be higher during the half, putting pressure on its margins. For example, its EBIT margin is expected to be 14% to 17.5%, compared to 28% during the second half of FY 2025.

Cogstate’s CEO, Brad O’Connor, commented:

Cogstate’s future has never looked brighter. We are seeing a record level of opportunities from an expanded customer base and across more indications, and those opportunities are now translating into higher levels of sales contracts.

The expected value of sales contracts to be executed in this December half is the second-highest half-year result in the company’s history and is a higher quality outcome because of the diversity of contracts. Our best half-year for contract sales was the December 2021 half, when we executed $54.5 million of sales contracts, with more than $30 million attributable to a single large trial. In contrast, the largest contract executed in the current half is just over $6 million.

The post Why is this ASX All Ords share crashing 30% today? appeared first on The Motley Fool Australia.

More reading

• Down 20% since November, are Bendigo Bank shares now a buy?
• 1 magnificent ASX dividend share down 19% to buy and hold for decades
• Alphabet stock jumped 13.9% in November. What’s next?
• Rare earths company ticks off key production milestone
• Charter Hall Group unveils 42.28c per security capital reallocation

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cogstate. The Motley Fool Australia has positions in and has recommended Cogstate. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX dividend shares have always been a favourite among Aussies seeking a steady passive income from reliable, well-established companies. By holding onto a quality stock for a long period of time, investors can benefit from the power of compounding and long-term business growth.

There are many ASX dividend shares out there which can offer this type of income. But there is one in particular which I think offers a fantastic buying opportunity right now: Sonic Healthcare Ltd (ASX: SHL).

Sonic Healthcare shares are trading in the red on Wednesday morning. At the time of writing, the shares are down 0.9% to $23 a piece.

Over the past month, the shares have climbed 8.9%. But after a steep sell-off following the company’s FY25 results announcement in August, the share price is 19.13% lower than this time last year.

Why are Sonic Healthcare shares a great ASX dividend buy today?

The ASX dividend stock is the seventh largest healthcare share on the ASX 200 Index, by market capitalisation. The company is a global leader in pathology and diagnostic imaging, operating across Australia, Europe, and the United States.

The business is well diversified and in a good position to benefit from long-term tailwinds amid an ageing population. 

As a diagnostics healthcare company, demand for Sonic Healthcare’s services are expected to boom in coming decades as older individuals have more need for regular and repeated pathology tests to help with any upcoming chronic illnesses. 

At the same time, there is also growing awareness among other age groups about the benefits of early disease detection and preventive health screening.

When it comes to its dividends, Sonic Healthcare offers an attractive yield. In FY25, the company declared it would pay a full-year dividend of $1.07 per share to investors. 

And after a tough period, the market is expecting the company’s dividends to grow steadily over the next few years.

Bell Potter forecasts dividends of $1.09 per share in FY26 and $1.11 in FY27. The consensus estimate is for a dividend yield of 4.6% in FY26.

Where do analysts think the share price will go next?

Analysts at Bell Potter have said they think the ASX dividend company is ready for a return to consistent growth. They also said investors should be snapping up the shares.

The broker has a buy rating and $33.30 target price on the shares. At the time of writing, this implies a 44.8% upside for investors over the next 12 months. 

Macquarie is a little less bullish on the shares. The broker has a buy rating and 12-month target price of $25.20 on the stock, although this still implies a potential 9.6% upside ahead.

The post 1 magnificent ASX dividend share down 19% to buy and hold for decades appeared first on The Motley Fool Australia.

More reading

• Buy BHP, Woolworths, and these ASX dividend shares
• Forget Westpac shares and buy these ASX dividend stocks
• 3 reasons to buy this $12 billion ASX 200 stock today
• Analysts think BHP and these ASX dividend shares are buys this week
• These ASX 200 shares could rise 40% to 90%

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

While much of tech saw red in November, it was a strong month for Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), with shares of the Google parent rising 13.9% from the closing bell on Oct. 31 to the end of November’s trading. The S&P 500 ticked up 0.1% over the same period, though it had dropped as much as 4.4% mid-month, while the tech-heavy Nasdaq Composite finished down 1.5%, having fallen as much as 6.9%. 

Fears of an artificial intelligence (AI) bubble weighed on much of the market, but Alphabet was able to shrug them off because, in large part, the company helped ignite this latest iteration of AI bubble talk in the first place.

Gemini 3 proves Google can compete without Nvidia’s chips

Google’s release of Gemini 3, its latest AI model, directly challenged Nvidia and OpenAI’s place at the heart of the AI boom. Gemini 3 was not only received as a significant improvement on the latest models from its competitors, but critically, it was trained not with Nvidia’s chips, but Google’s.

These chips — called TPUs — are specifically designed and optimized for the kinds of operations that Google uses to train its models, making them both cheaper to produce and cheaper to run. This was a big moment for the industry, which had been largely operating under the assumption that in order to produce the best AI models, you needed Nvidia’s latest GPUs. 

Gemini 3’s obvious quality is a wake-up call for Nvidia and other semiconductor companies. If Google continues down this path and other hyperscalers follow, Nvidia’s pricing power could be in danger.

It’s also a major win for Alphabet, validating Google’s long-term bet on custom silicon.

Google must renegotiate its search contracts every year

December hasn’t been as kind to Alphabet shares, which are down slightly in the first days of the month. On Friday, a judge ordered Google to limit its default search contracts to a maximum of one year as part of an earlier ruling that the company had built a search and advertising monopoly. The company must now renegotiate its search contracts each year, including a critical deal with Apple, which makes it the go-to iPhone search engine.

I think that Alphabet is one of the best picks among big tech. If AI delivers on its promise, Alphabet will reap the rewards. If it doesn’t, Alphabet’s stock will undoubtedly get hit, but its core business will remain incredibly strong, and shares will recover.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Alphabet stock jumped 13.9% in November. What’s next? appeared first on The Motley Fool Australia.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

More reading

• Here’s why Alphabet is the best-performing “Magnificent Seven” stock in 2025 (and why it has room to run in 2026)
• Prediction: This will be the world’s largest company by year-end 2026 (Hint: It’s not Nvidia)
• Better $3 trillion AI stock to buy now: Microsoft or Alphabet
• What are the 5 top artificial intelligence (AI) stocks to buy right now?
• Screaming buy? This ASX ETF has returned 54% a year since 2022

Johnny Rice has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Apple, and Nvidia. The Motley Fool Australia has recommended Alphabet, Apple, and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Shares in Meteoric Resources Ltd (ASX: MEI) were trading higher on Wednesday after the company announced it had produced its first batch of rare earths from its recently-constructed pilot plant in Brazil.

The company said in a statement to the ASX that commissioning of the plant started with the introduction of low-grade clay ore into the plant over a two-week period.

Several technical processes were then carried out, the company said.

As it told the ASX:

The pilot plant further validates and optimises the flowsheet and tests different ore types from the Caldeira Project. Data generated from the pilot campaigns will be incorporated into the Caldeira Project definitive feasibility study (DFS) currently being undertaken by Ausenco.

New ores to be tested

Having been tested using low-grade ore, the pilot plant would now move on to ores with grades more typical of the company’s Brazilian deposit.

Technical imporvements could also be made, the company said.

The pilot plant also provides an opportunity to pilot the separation of rare earths by solvent extraction and other technologies such as flash joule heating (FJH). During the commissioning and early operation several opportunities have already been realised which will be reflected in the definitive feasibility study which is currently in progress.  

Meteoric Resources Managing Director Stuart Gale said it was a key milestone for the company.

It’s great to deliver our first batch of mixed rare earth carbonate (MREC) from the Caldeira Project. The team have done an excellent job in the development of the pilot plant – from acquisition of key equipment, recruitment of operators, construction and commissioning. This now places Meteoric in a small group of global companies with the ability to independently and consistently produce MREC product.

Mr Gale said the pilot plant’s design was based on extensive test work conducted at Australian government agency ANSTO, “including four continuous pilot runs of five days each”.

This foundation allows the pilot plant to expand upon the results achieved at ANSTO and simultaneously facilitate the training of plant operators. The pilot plant enables ongoing refinement of key project parameters and process optimisation, strengthening our understanding of the Caldeira Project. Combined with our expanding geological intellectual property, this pilot plant establishes a strong foundation for enhancing long-term project value.

Meteoric Resources shares were trading 3.3% higher at 15.5 cents on the news on Wednesday.

Macquarie has a 12-month price target of 39 cents on Meteoric Resources shares, saying its progress on the pilot plant “will enable the company to start off-take discussions with downstream customers, a key near-term catalyst”.

The post Rare earths company ticks off key production milestone appeared first on The Motley Fool Australia.

More reading

• Why Macquarie expects this surging ASX All Ords mining stock to rocket another 160%
• Meet the ASX rare earths stock that could rocket 80%
• Why Meteoric Resources, Race, Temple & Webster, and West African shares are falling today
• Why James Hardie, Meteoric Resources, Pilbara Minerals, and SKS shares are rising today

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Charter Hall Group (ASX: CHC) share price is in focus after the company announced a capital reallocation of 42.28 cents per security, following securityholder approval at its November AGM. Key features include a return of capital and a special fully franked dividend, with no cash changing hands for investors.

What did Charter Hall Group report?

• Capital reallocation of 42.28 cents per stapled security approved and set for 18 December 2025
• Return of capital of 11.61 cents per Charter Hall Limited (CHL) share
• Special fully franked dividend of 30.67 cents per CHL share (franking credit: 13.14 cents)
• No cash payment or issue/cancellation of securities for securityholders
• ATO draft class ruling obtained; formal ruling expected within six weeks

What else do investors need to know?

Securityholders will not receive any cash from the capital reallocation. Instead, the capital will shift from Charter Hall Limited to Charter Hall Property Trust, automatically adjusting the cost base for each security. This may have future tax implications for investors.

The capital reallocation is scheduled for 18 December 2025, with the record date on 17 December 2025. Confirmation letters and statements will be sent out to investors on or about 9 January 2026.

What’s next for Charter Hall Group?

Charter Hall expects the capital reallocation to support the group’s ongoing capital management strategy, enhancing transparency and cost base alignment for investors. The company awaits the final ATO class ruling to confirm the tax treatment for securityholders.

Management says key documents, including the AGM Notice, Explanatory Memorandum, and tax ruling, will be available on the company’s website to support investor understanding.

Charter Hall Group share price snapshot

Over the past 12 months, Charter Hall Group shares have climbed 67%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen around 2% over the same period.

View Original Announcement

The post Charter Hall Group unveils 42.28c per security capital reallocation appeared first on The Motley Fool Australia.

More reading

• TPG Telecom lifts free float after $73 million Retail Reinvestment Plan
• Ampol delivers $649m RCOP EBITDA and updates investors on strategic growth
• GQG Partners share price in focus after November FUM update
• Ramelius Resources launches share buy-back: What investors need to know
• 2 compelling ASX 200 shares this fund manager rates as buys

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

ASX All Ords gold stock Strickland Metals Ltd (ASX: STK) is marching higher today.

Strickland Metals shares closed yesterday trading for 18 cents apiece. In morning trade on Wednesday, shares are changing hands for 18.5 cents apiece, up 2.8%.

For some context, the All Ordinaries Index (ASX: XAO) is also just about flat at this same time.

With today’s intraday gains factored in, the Strickland Metals share price is up 105.6% in 2025.

Here’s what’s happening with the ASX gold miner.

ASX All Ords gold stock announces 1.2-million-ounce MRE

Stickland Metals shares are in the green today after the ASX All Ords gold stock announced a maiden Mineral Resource Estimate (MRE) for the Gradina Deposit. Gradina sits within Stickland’s 100%-owned Rogozna Gold and Base Metals Project, located in Serbia.

The maiden MRE came in at 12 million tonnes at 3 grams of gold per tonne (12Mt at 3g/t Au). That equates to 1.2 million ounces of gold. And it lifts the total inferred MRE at the Rogozna Project by 16% to 8.6 million ounces of gold equivalent (AuEq).

The miner highlighted that the discovery cost was only US$10 per ounce.

And the ASX All Ords gold stock noted that the mineralisation remains open in all directions, with “significant near-term growth potential” in a number of adjacent areas where it will conduct further exploratory drilling in 2026.

Drilling is ongoing at the Rogozna Project, with two rigs drilling the so-called Gradina “gap zone”, while three rigs are focused on discovery drilling across the broader project area.

Strickland said it is well-funded to support the ongoing drilling campaign, reporting cash and liquids of $41.8 million as at 30 September.

What did management say?

Commenting on the maiden resource estimate that’s helping boost the ASX All Ords gold stock today, Strickland managing director Paul L’Herpiniere, said, “Delivering a maiden resource of 1.2Moz Au for the Gradina Deposit, with an average grade of 3.0g/t Au, is an outstanding result which reinforces the quality and scale of the Rogozna Project.”

L’Herpiniere added:

Recent drilling at Gradina has delivered some exceptional intercepts of high-grade, gold-dominant mineralisation across the length of the deposit, underpinning a substantial maiden MRE at a discovery cost of just $US10/oz. By global standards, this is a very high return on exploration investment, highlighting the value that Rogozna’s large-scale mineralisation style offers.

Looking ahead, L’Herpiniere said, “This latest update follows the substantial MRE updates posted earlier this year and sets the scene for continued growth into 2026, with an updated MRE for the cornerstone Shanac Deposit due in early 2026.”

The post Up 106% in 2025, ASX All Ords gold stock lifting today on 1.2-million-ounce reserve boost appeared first on The Motley Fool Australia.

More reading

• Why this surging ASX All Ords gold stock is tipped to rocket another 233%
• Up 146% in a year, ASX All Ords gold stock reveals ‘significant upside’ exploration results
• Guess which ASX All Ords gold stock is leaping 12% on big Serbian news
• Why Breville, Flight Centre, Mineral Resources, and Strickland shares are shooting higher

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Orthocell Ltd (ASX: OCC) shares are having a strong session on Wednesday.

In morning trade, the ASX healthcare stock is up 7% to $1.09.

Why is this ASX healthcare stock jumping?

Investors have been buying the regenerative medicine company’s shares after it announced the first commercial sales of its Remplir product in Hong Kong. Management notes that this marks a key milestone in its Asian growth strategy.

Remplir is a collagen wrap used in nerve repair surgery to improve regeneration of damaged nerves and patient outcomes.

According to the release, these initial sales follow the successful introduction of Remplir in Hong Kong, including its first surgical use and strong reception at the Hong Kong Orthopaedic Association (HKOA) 45th Annual Congress.

The first sales were to MontsMed and provide immediate in-market availability and are expected to support multiple downstream sales as surgeons adopt the technology.

The ASX healthcare stock notes that Hong Kong represents a significant growth opportunity, serving as a strategic entry point into the Guangdong–Hong Kong–Macao Greater Bay Area (GBA). This is a rapidly developing healthcare market of approximately 100 million people.

Strongly positioned

Together with MontsMed, Orthocell is strongly positioned to drive market penetration through leading hospitals and specialist surgeons across the region.

To further accelerate commercial traction, Orthocell’s recently appointed Asia Pacific commercial director will be active in market from the first quarter of 2026.

It highlights that working closely with MontsMed, the commercial director will support awareness-building initiatives, surgeon education, and the expansion of Remplir sales across Hong Kong, with broader responsibilities across Australia and Asia.

Commenting on the news, Orthocell’s CEO and managing director, Paul Anderson, said:

First Hong Kong sales represent an important commercial milestone for Orthocell and a strong validation of Remplir’s clinical value. We are well positioned to support MontsMed in driving adoption across leading hospitals in Hong Kong and the Greater Bay Area. We are executing our commercialisation strategy with discipline, and today’s achievement marks another step forward in establishing Remplir as a new standard of care in peripheral nerve repair.

The company also notes that with ~$50 million in cash and no debt, it remains strongly funded and well-positioned to drive rapid product adoption and deliver a step change in revenue in FY 2026.

It also advised that the Remplir rollout in the US$1.6 billion US market continues to build momentum. It revealed that in-country representatives are working closely with distributors to gain hospital approvals, onboard surgeons, and establish active accounts.

The post Guess which ASX healthcare stock is jumping 7% on big news appeared first on The Motley Fool Australia.

More reading

• Guess which All Ords stock is racing higher on big news

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Orthocell. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Shares in consumer goods retailer JB Hi-Fi Ltd (ASX: JBH) have come down from levels well above $100 recently, which the team at RBC Capital Markets says creates a buying opportunity.

The shares closed at $113.52 the day before the company’s annual general meeting on October 30, when the company also released a trading update which said sales for the first quarter were “in line with the group’s expectations”.

The market did not appear to like the numbers in the update, however, which showed that comparable sales at JB Hi-Fi Australia were up 5% compared with the same period the previous year, and sales at The Good Guys were up 2.4%.

Performing well on costs

RBC Capital Markets has initiated coverage of JB Hi-Fi with a sector perform rating, and is positive on the company’s outlook, saying the company has an “industry-best cost base efficiency”.

In terms of competition, however, they are forecasting heavy market share gains for online competitor Amazon.

RBC analysts had this to say about JB Hi-Fi:

JB Hi-Fi runs one of the leanest cost of doing business margins and capex/ sales ratios in global consumer electronics retail. JB Hi-Fi’s seamless omnichannel experience is a competitive advantage, in our view. Surveys indicate about 85% of consumers still want to shop in-store to varying extents, and we forecast about 60% – 70% of JB HiFi’s sales growth to come from bricks and mortar over the next three years.  

In terms of specific products which will provide a boost, the end of support for Windows 10 “is a hard catalyst for a refresh with Microsoft‘s own support stressing security risks following end-of-support”.

RBC also notes that there is room for further growth in the robot vacuum sector, with penetration being low in Australia and forecasted to grow at a rate of up to 16.2% year over year.

Amazon looms as major competitor

On the downside, Amazon “poses a material and growing competitive threat”, RBC said.

Amazon now has the levers of range, price and fulfilment in place to facilitate a large step-change in market share, in our view. We estimate Amazon’s share of total Australian online retail will about double over the next 5 years, to about 24%. Relative to comparable markets, this level of penetration is still low.

RBC stated that, over the Black Friday sales period, Amazon was approximately 2.3% cheaper than JB Hi-Fi on average across the nine categories they surveyed.

RBC has a price target of $101 on JB Hi-Fi shares, compared with the company’s closing price of $92.92 on Tuesday.

JB Hi-Fi also pays a fully franked dividend of about 4% according to the ASX website.

The post How high does RBC Capital think JB Hi-Fi shares can go? appeared first on The Motley Fool Australia.

More reading

• Macquarie names its top ASX consumer staples and consumer discretionary stock picks
• 3 ASX shares that I think are buys for both growth and dividends
• Warning! Analysts name 3 ASX 200 stocks to sell today
• What are Macquarie’s key picks in the retail space?

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon and Microsoft. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool Australia has recommended Amazon and Microsoft. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.